{"url_path":"/sec/limnw/8-k/2026-06-03/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity Securities.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-26-070173-index.html","accession_number":"0001104659-26-070173","cik":"0001971387","ticker":"LIMN","issuer_name":"Liminatus Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-26-070173-index.html","primary_entity_key":"0001971387","primary_entity_name":"Liminatus Pharma, Inc."},"word_count":152,"has_tables":true,"body_markdown":"Item 3.02 Unregistered Sales of Equity Securities.\n\n \n\nThe Company issued the Inducement Warrants pursuant\nto the exemption from the registration requirements of the Securities Act available under Section 4(a)(2) and Rule 506(b) of Regulation\nD promulgated thereunder and such securities may not be re-offered in the United States except pursuant to an effective registration statement\nor an applicable exemption from the registration requirements of the Securities Act and any applicable state securities laws. The description\nof the Inducement Warrants under Item 1.01 of this Current Report is incorporated herein by reference. The forms of the New Black-Scholes\nWarrant and the New Change of Control Warrant are filed as Exhibits 4.1 and 4.2, respectively, to this Current Report and are incorporated\nherein by reference.\n\n \n\nNeither this Current Report on Form 8-K nor any exhibit attached hereto\nis an offer to sell or the solicitation of an offer to buy securities of the Company."}